Overactive Bladder Education
NCT02505607 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22
Last updated 2015-12-31
Summary
Overactive bladder (OAB) is a common, chronic condition, characterized by urinary "urgency, with or without urge incontinence, usually with frequency and nocturia." Treatment adherence is a major barrier to management of OAB and drug continuation is poor. Many factors may play a role in non-adherence to medication management of OAB including drug cost, side effects, and a lack of understanding of the disease and treatment process.Studies show that recall of disease information and treatment is often suboptimal. Literature shows that providing written materials is an efficacious way to aid in recall. Based on known poor adherence to OAB medication treatment and the clear role patient education methods have on patient information recall, the investigators believe that improvement of participant education through use of a OAB care plan will improve participant understanding and treatment adherence.
Through this randomized trial, the investigators plan to evaluate whether implementation of a OAB Care Plan improves understanding of disease and treatment options, treatment success, and satisfaction.
This is a prospective, randomized, controlled study of OAB counseling in new patients presenting to the Urogynecology offices of Hartford Hospital. All new patients with a diagnosis of OAB will be offered participation. All consenting participants will be randomized 1:1 to one of two groups: 1) Standard Care group or 2) Care Plan group. In the Standard Care group, participants will be counseled as the physician routinely counsels patients about OAB, in the Care Plan group, participants will be counseled a printed "Overactive Bladder Plan of Care" information sheet. At the end of the visit, the participant will complete a Baseline Survey. The Baseline Survey includes basic demographic information, a physician satisfaction survey, and a OAB knowledge survey. The participant will return for follow up as directed by the physician.
At the follow up visit, participants in both groups will complete a Followup Survey. The Followup Survey will be completed before the participant sees the physician. The Followup Survey assesses OAB knowledge.
Eight months after the baseline visit, each participant's chart will be reviewed for final data collection. If a participant progresses to a treatment method where she is satisfied and would like to remain, this will be documented.
Conditions
- Urinary Bladder, Overactive
- Urinary Incontinence, Urge
Interventions
- OTHER
-
Overactive Bladder Care Plan counseling
Use of a printed "Overactive Bladder Plan of Care" information sheet.
Sponsors & Collaborators
-
Hartford Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 89 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-07-31
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
Countries
- United States
Study Locations
More Related Trials
-
Validation of a Real-time Urodynamic Measure of Urinary Urgency
NCT00909428 ·Status: COMPLETED ·Phase: PHASE4
-
Prevalence and Risk Factors Nocturnal Polyuria in Female OAB
NCT03810027 ·Status: COMPLETED
-
Combined Behavioral and Drug Treatment of Overactive Bladder in Men
NCT01175382 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Overactive Bladder (OAB) Drink Advice Study
NCT00982241 ·Status: WITHDRAWN ·Phase: NA
-
Herbal Patch for Overactive Bladder
NCT03532789 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A
NCT04305743 ·Status: RECRUITING ·Phase: PHASE4
-
A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
NCT02386072 ·Status: COMPLETED
-
Caffeine Reduction and Overactive Bladder Symptoms
NCT00754260 ·Status: TERMINATED ·Phase: NA
-
Diversity in Patients With OAB
NCT05903105 ·Status: NOT_YET_RECRUITING
-
Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection
NCT05719285 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder
NCT00780832 ·Status: TERMINATED ·Phase: NA
-
OnabotulinumtoxinA Bladder Injection Study
NCT03523091 ·Status: TERMINATED ·Phase: PHASE4
-
Prevalence And Risk Factors of Overactive Bladder Syndrome Among Egyptian Medical Students, and Their Impact On Health-Related Quality Of Life
NCT07044778 ·Status: COMPLETED
-
Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrusor Injections
NCT07025044 ·Status: RECRUITING
-
Behavioral Treatment of Overactive Bladder in Men
NCT01187498 ·Status: COMPLETED ·Phase: PHASE3
-
Sexual Function Trial of Overactive Bladder: Medication Versus PTNS
NCT03500146 ·Status: COMPLETED
-
Behavioural Therapy With Checklist for Overactive Bladder
NCT03662893 ·Status: COMPLETED ·Phase: NA
-
A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo
NCT00350636 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)
NCT01099345 ·Status: TERMINATED
-
Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects
NCT01029015 ·Status: COMPLETED
-
Developing a Simple Test to Diagnose Overactive Bladder
NCT05572918 ·Status: UNKNOWN
-
Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder
NCT04020510 ·Status: RECRUITING ·Phase: PHASE4
-
Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder
NCT00773552 ·Status: WITHDRAWN ·Phase: PHASE4
-
Oxybutynin and Omega-3 for OAB (Overactive Bladder)
NCT02070042 ·Status: TERMINATED ·Phase: NA
-
Comparing Treatments for Overactive Bladder in Taiwan: A Study of Outcomes
NCT07025642 ·Status: RECRUITING ·Phase: NA